ROR1 and female reproductive organ cancer: Characterized by a paucity of expression in adult tissues yet overexpressed in multiple malignancies (John and Ford, 2022), receptor tyrosine kinase-like orphan receptor 1 (ROR1) has emerged as a target of interest in precision medicine, including gynecological cancers (Liu et al., 2025a; Liu et al., 2025b).